Vitamin D administration boosts FGF23 concentrations
Administration of vitamin D or activated vitamin D >2,000 IU/day leads to a significant increase in concentrations of phosphaturic hormone fibroblast growth factor 23 (FGF23), a risk marker of cardiovascular and all-cause mortality, particularly in patients with end-stage renal disease (ESRD) or heart failure (HF), a study has shown.